Ambio
Manufacturing · South Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1024 Dittman Ct, Beech Island, South Car...Phone Number
(803) 442-7590Website
www.ambiorx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ambio
Ambio is an innovative biotech company developing novel peptide drugs, biosimilar, bioequivalent, and other complex generic drugs, with unmatched expertise and technological advances in synthetic peptide drug development. Ambio has expertise in not only developing complex synthetic peptides to replace recombinant brand peptides but most importantly understanding of what the FDA's expectation is for the regulatory approval process in such cases. The company is partnering to launch biosimilar drugs targeting blockbuster indications and advancing the company's own pipeline of novel drugs to improve upon existing biologics and peptide drugs in the therapeutic areas of diabetes, obesity, and beyond. The company's mission is to provide high quality and affordable drugs to patients around the world.Explore more
Ambio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ambio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Ambio
Earning: See what the market has to say on Ambio recently announced quarterly report
Product Launch: Get notified when Ambio launches new products
Ambio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Ambio is spiking on competitors!
Funding: Get notified immidiatlly once Ambio has new funding data
Click to see if Ambio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Ambio has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Ambio
Compare insights from companies similar to Ambio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ambio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ambio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ambio.
Ambio Tech Stack
A closer look at the technologies used by Ambio
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Ambio
Sign Up For FreeTo access detailed company insights
Ambio is an innovative biotech company developing novel peptide drugs, biosimilar, bioequivalent, and other complex generic drugs, with unmatched expertise and technological advances in synthetic peptide drug development. Ambio has expertise in not only developing complex synthetic peptides to replace recombinant brand peptides but most importantly... Read More
